What combination of treatments can help decrease cancer risk in menopausal women?

• A. Tamoxifen Alone
• B. Estrogen Alone
• C. Estrogen and Progesterone Together
• D. Progesterone Alone

Answer: (C)

The combination of estrogen and progesterone together is beneficial in decreasing cancer risk in menopausal women, particularly in the context of endometrial cancer. When estrogen is used alone, it can stimulate the endometrium (the lining of the uterus), increasing the risk of endometrial hyperplasia and subsequent cancer. Progesterone counteracts the effects of estrogen on the endometrium, helping to protect against the development of endometrial cancer.

In hormone replacement therapy (HRT) for menopausal symptoms, when estrogen is administered, adding progesterone is important for women who have not had a hysterectomy. This combination helps maintain hormonal balance and reduces the risk associated with unopposed estrogen therapy.

Other treatment options discussed, such as tamoxifen alone, estrogen alone, and progesterone alone, do not provide the same protective benefits against cancer in this specific context. Tamoxifen, for instance, is typically used for breast cancer treatment and risk reduction, not primarily for menopausal symptom relief or endometrial protection. Therefore, the use of estrogen and progesterone together represents a balanced approach to managing menopausal symptoms while minimizing cancer risks.